Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Hormonal pathology of the endometrium
Liane Deligdisch
Icahn School of Medicine at Mount Sinai
Pathology, Molecular and Cell-Based Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
183
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Hormonal pathology of the endometrium'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Endometrium
100%
Secretory Change
100%
Hormone Therapy
66%
Oral Contraceptives
66%
Hormone Replacement Therapy
66%
Histological Pattern
66%
Polyps
66%
Endometrial Hyperplasia
66%
Endometrial Intraepithelial Neoplasia
66%
Glandular Hyperplasia
66%
Spiral Artery
66%
Glandular Proliferation
66%
Endometrial Atrophy
66%
Tissue Sampling
33%
Endometrial Tissue
33%
Causal Relationship
33%
Estrogen
33%
Uterine Leiomyoma
33%
Progesterone
33%
Breast Carcinoma
33%
Granulocytes
33%
Uterus
33%
Blood Vessels
33%
Mucinous
33%
Ovarian Stimulation
33%
Neoplastic Transformation
33%
Stromal Edema
33%
Hormonal Stimulation
33%
Leiomyoma
33%
Estrogen Effect
33%
Prolonged Use
33%
Antitumoral
33%
Endometrioid Carcinoma
33%
Adenomyosis
33%
Promptness
33%
Unopposed Estrogen
33%
Involution
33%
Decidual
33%
Cyclic Changes
33%
Hyaline Degeneration
33%
Stromal Hyperplasia
33%
Tamoxifen Therapy
33%
Estrogen Alone
33%
Endometrial Polyp
33%
Atrophic Endometrium
33%
Lupron
33%
Endometrial Development
33%
Progesterone Therapy
33%
Decidual Reaction
33%
Luteal Phase Defect
33%
Secretory Glands
33%
Ovulation Induction Therapy
33%
Steroid Sex Hormones
33%
Non-endometrioid Carcinoma
33%
Epithelial Metaplasia
33%
Medicine and Dentistry
Endometrium
100%
Hyperplasia
100%
Stroma
75%
Neoplasm
50%
Hormone Therapy
50%
Progesterone
50%
Oral Contraceptive
50%
Arteriole
50%
Hormone Substitution
50%
Ovulation Induction
50%
Polyp
50%
Tamoxifen
50%
Endometrium Atrophy
50%
Maturation
25%
Carcinoma
25%
Sex Hormone
25%
Edema
25%
Metaplasia
25%
Granulocyte
25%
Breast Carcinoma
25%
Uterine Fibroid
25%
Angioleiomyoma
25%
Leuprorelin
25%
Eosinophilic
25%
Vascular Bundle
25%
Adenomyosis
25%
Endometrial Hyperplasia
25%
Hyaline Degeneration
25%
Endometrial Polyp
25%
Involution
25%
Hormonal Effect
25%
Luteal Insufficiency
25%
Decidualization
25%
Causal Relationship
25%